Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

is open and Janssen plans to enroll 110 patients worldwide.
  • Phase Ib/II dose escalating study of ibrutinib in combination with R-CHOP in patients with newly diagnosed CD20 positive non-Hodgkin's lymphoma. The purpose of this study is to identify a safe and tolerable dose of ibrutinib in combination with R-CHOP, once a safe dose is established the study will expand and report responses of this combination in patients with newly diagnosed DLBCL. This global, multi-center study, conducted by Janssen, is open and Janssen plans to enroll 33 patients.
  • Phase II study of ibrutinib in subjects with relapsed or refractory multiple myeloma (MM): This is a Phase II, multi-center, open-label trial designed trial to assess the safety and efficacy of ibrutinib single agent and in combination with dexamethasone in subjects with relapsed or relapsed MM. This study is conducted by Pharmacyclics and is currently exploring ibrutinib administration at 560 mg in combination with dexamethasone. Two further cohorts are planned to be explored; 840 mg with dexamethasone and 840 mg as a single agent. The Company anticipates an update on this study will be provided by year end 2013.
  • Phase II open-label, multicenter, single-arm study of monotherapy ibrutinib in subjects with relapsed or refractory follicular lymphoma. The primary endpoint of this study is objective response rate. Janssen plans to enroll 110 patients in this study.

    • PCYC has received Orphan Drug and Fast Track designation for ibrutinib treatment of chronic lymphocytic leukemia last year. The FDA has also granted Orphan Drug and Fast Track designation most recently to ibrutinib for the treatment of mantle cell lymphoma.  A US orphan drug designation provides the drug developer with several benefits and incentives related to the orphan drug, including a 7-year period of U.S. marketing exclusivity if the drug is the first of its type approved for the specified indication. Fast tra
    '/>"/>

    SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
    2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    7. Pharmasset Reports Fiscal Year End 2011 Financial Results
    8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
    10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
    11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... -- New interactive learning forums will ... of the medical device industry at the 2013 ... from June 18-20 in Philadelphia ... ) , These all-new MedTech Innovate ... presentations and implementable solutions on the most cutting-edge ...
    (Date:5/17/2013)... FL (PRWEB) May 17, 2013 Men’s skin ... La-roche Posay ) and has been known to ... Although some men may be far from puberty, other acne ... clogging pores, causing breakouts, and threatening skin with unsightly acne ... advice from Men’s Health on how to reduce ...
    (Date:5/17/2013)... Tooth decay is an epidemic in American children ... disease. The World Health Organization says that worldwide, 60–90% ... cavities. What are the long-term effects of this transmissible infection? ... between the oral bacterial imbalance and serious systemic issues like ... it is also 100% preventable? Answer: there has been no ...
    (Date:5/16/2013)... Hills, Ill. (PRWEB) May 16, 2013 ... benchtop and portable models, from Cole-Parmer is designed ... The enhanced line includes: , The new ... are true workhorses in the lab. They ensure ... serum and plasma specimen separation. Their standard four-place ...
    Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3Cole-Parmer Offers Enhanced Selection of Centrifuges 2
    ... James Tour have brought graphite,s potential as a mass ... created the potential for reprogrammable gate arrays that could ... In a paper published in the online ... Alexander Sinitskii show how they,ve used industry-standard lithographic techniques ...
    ... FAIRFAX, Va., Sept. 9 SRA International, Inc. (NYSE: ... services and solutions to government organizations and commercial clients, today announced ... Institute of Texas (CPRIT) to provide scientific peer review services. The ... are exercised. Work on the contract began July 1, 2009. ...
    ... , , FARMINGDALE, N.Y., Sept. 9 ... developer of minimally invasive ultrasonic medical device technology, which ... and worldwide for other acute health conditions, has entered ... privately-held Novotech Solutions ("Novotech"), based in Bangalore, India. Novotech ...
    Cached Biology Technology:Graphitic memory techniques advance at Rice 2Graphitic memory techniques advance at Rice 3SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas 2SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas 3Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan 2Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan 3
    (Date:5/16/2013)... PA, May 16, 2013 The relationship between ... (IQ) has not been clear. Schizophrenia is commonly ... disability. There are clues that reduced IQ may ... For example, reduced cognitive ability may precede the ... be present in healthy relatives of people diagnosed ...
    (Date:5/16/2013)... Infections can trigger hematopoiesis at sites outside the bone ... skin.Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that ... medullary" formation of blood cells. , Balanced hematopoiesis is ... fetal development, hematopoiesis takes place mainly in the liver ... the bone marrow, and this tissue normally serves as ...
    (Date:5/16/2013)... YORK , May 16, 2013 /PRNewswire/ ... research report is available in its catalogue: ... Forecast & Opportunities, 2018 ... protection and old security practises such as ... the growth of biometric technologies in last ...
    Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Herpes infections: Natural killer cells activate hematopoiesis 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
    ... Salk Institute for Biological Studies and Oregon State University has ... rhythmic growth at night and allow them to compete when ... report in this week,s issue of the journal PLoS ... plant growth hormones, plant light sensors and circadian rhythms that ...
    ... University in St. Louis has sequenced the genome of a ... nitrogen fixation in one little cell during two distinct ... and Irene Koechig Professor in Arts & Sciences, spearheaded the ... ATCC 51142 to understand the workings of this species that ...
    ... and advertising affect our emotions, and if we understand ... a new study in the Journal of Consumer ... and Terry L. Childers (all University of Kentucky) examined ... found that people who made the healthiest choices had ...
    Cached Biology News:Biologists identify genes controlling rhythmic plant growth 2Biologists identify genes controlling rhythmic plant growth 3Biologists identify genes controlling rhythmic plant growth 4Cyanobacterium sequenced features rare linear chromosome 2Cyanobacterium sequenced features rare linear chromosome 3Pictures of hot fudge sundaes arouse: Understanding emotions improves our food choices 2
    ... the 9, 10, 12, and 13 positions. It ... for the quantification of 13(S)-HODE by GC- or ... linoleic acid with plant and mammalian lipoxygenases. It ... tumor cells to the endothelium at concentrations around ...
    ...
    ...
    ...
    Biology Products: